M.V.I.-12 Drug Patent Profile
✉ Email this page to a colleague
When do M.v.i.-12 patents expire, and when can generic versions of M.v.i.-12 launch?
M.v.i.-12 is a drug marketed by Hospira and Teligent and is included in two NDAs.
The generic ingredient in M.V.I.-12 is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e profile page.
Summary for M.V.I.-12
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | M.V.I.-12 at DailyMed |